CytoSorbents Corporation - Rasio nilai perusahaan marang pendapatan CTSO

Cytosorbents (CTSO) leads the blood purification systems segment, expanding its presence in cardiac surgery. The price-to-sales multiple dynamics on the GURU.Markets daily chart confirm this trend, where the value of 1131.61 expresses the metric level. Growth is driven by automated cartridges with digital control, while strict patents and complex certification requirements in the EU and US guarantee business stability.
CTSO (cytosorbents.com): rincian analitis lan laporan miturut indikator

This indicator reflects the ratio of enterprise value to revenue, excluding the impact of debt load to provide an objective assessment of the asset's market value. In the context of Cytosorbents (CTSO), the ratio of enterprise value to annual revenue is critically important, as high capital expenditure and regulatory complexities with the FDA could lead to a company revaluation in the event of a liquidity shortage.